These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38259728)

  • 1. The "Big Three" in biocompatibility testing of medical devices: implementation of alternatives to animal experimentation-are we there yet?
    Kanďárová H; Pôbiš P
    Front Toxicol; 2023; 5():1337468. PubMed ID: 38259728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Qualification of a non-animal vaginal irritation method admitted as nonclinical assessment model (NAM) in the Incubator Phase of the United States Food and Drug Administration (US FDA) Medical Devices Development Tool (MDDT).
    Costin GE; Hill E; Brown J; Clippinger AJ
    Toxicol In Vitro; 2020 Feb; 62():104680. PubMed ID: 31626901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Sensitive
    Pôbiš P; Kubalcová J; Milasová T; Kandárová H
    Altern Lab Anim; 2024 Sep; 52(5):261-275. PubMed ID: 39168512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biocompatibility of polymer-based biomaterials and medical devices - regulations, in vitro screening and risk-management.
    Bernard M; Jubeli E; Pungente MD; Yagoubi N
    Biomater Sci; 2018 Jul; 6(8):2025-2053. PubMed ID: 29968869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ISO 10993-23 In vitro irritation testing for medical devices: Substantiating applicability to mild irritants and non-extractables.
    Pellevoisin C; Coleman KP; Hoffmann S
    Toxicol In Vitro; 2022 Aug; 82():105371. PubMed ID: 35487444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From in vivo to in vitro: The medical device testing paradigm shift.
    Kerecman Myers D; Goldberg AM; Poth A; Wolf MF; Carraway J; McKim J; Coleman KP; Hutchinson R; Brown R; Krug HF; Bahinski A; Hartung T
    ALTEX; 2017; 34(4):479-500. PubMed ID: 28539002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biocompatibility assessments for medical devices - evolving regulatory considerations.
    Reeve L; Baldrick P
    Expert Rev Med Devices; 2017 Feb; 14(2):161-167. PubMed ID: 28080154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leveraging biomarkers and translational medicine for preclinical safety - Lessons for advancing the validation of alternatives to animal testing.
    Hartung T; King NMP; Kleinstreuer N; Leist M; Tagle DA
    ALTEX; 2024; 41(4):545-566. PubMed ID: 39440996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical Device Industry Approaches for Addressing Sources of Failing Cytotoxicity Scores.
    Räägel H; Turley A; Fish T; Franson J; Rollins T; Campbell S; Jorgensen MR
    Biomed Instrum Technol; 2021 May; 55(2):69-84. PubMed ID: 34043008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current EU regulatory requirements for the assessment of chemicals and cosmetic products: challenges and opportunities for introducing new approach methodologies.
    Pistollato F; Madia F; Corvi R; Munn S; Grignard E; Paini A; Worth A; Bal-Price A; Prieto P; Casati S; Berggren E; Bopp SK; Zuang V
    Arch Toxicol; 2021 Jun; 95(6):1867-1897. PubMed ID: 33851225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety assessment and global regulatory requirements for genetic toxicity evaluations of medical devices.
    Przygoda RT
    Environ Mol Mutagen; 2017 Jun; 58(5):375-379. PubMed ID: 28573657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro human skin irritation test for evaluation of medical device extracts.
    Casas JW; Lewerenz GM; Rankin EA; Willoughby JA; Blakeman LC; McKim JM; Coleman KP
    Toxicol In Vitro; 2013 Dec; 27(8):2175-83. PubMed ID: 23999410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The suitability of reconstructed human epidermis models for medical device irritation assessment: A comparison of In Vitro and In Vivo testing results.
    De Jong WH; Carraway JW; Liu C; Fan C; Liu J; Turley AP; Rollins TS; Coleman KP
    Toxicol In Vitro; 2020 Dec; 69():104995. PubMed ID: 32891721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of Alternative In Vitro Methods to Animal Testing: Concepts, Challenges, Processes and Tools.
    Griesinger C; Desprez B; Coecke S; Casey W; Zuang V
    Adv Exp Med Biol; 2016; 856():65-132. PubMed ID: 27671720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
    Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM
    Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the potential of reconstructed human epithelial tissue models for safety assessment of intraoral medical devices.
    Pôbiš P; Milasová T; Kandarova H
    Toxicol In Vitro; 2024 Oct; ():105956. PubMed ID: 39433148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical device regulations and testing for toxicologic pathologists.
    Schuh JC
    Toxicol Pathol; 2008 Jan; 36(1):63-9. PubMed ID: 18337222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SkinEthic™ RHE for in vitro evaluation of skin irritation of medical device extracts.
    Pellevoisin C; Videau C; Briotet D; Grégoire C; Tornier C; Alonso A; Rigaudeau AS; Bouez C; Seyler N
    Toxicol In Vitro; 2018 Aug; 50():418-425. PubMed ID: 29339149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biocompatibility assessment of biomaterials used in orthopedic devices: An overview (Review).
    Huzum B; Puha B; Necoara RM; Gheorghevici S; Puha G; Filip A; Sirbu PD; Alexa O
    Exp Ther Med; 2021 Nov; 22(5):1315. PubMed ID: 34630669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.